Early discharge
ProcedureIn the early discharge group, patients are actively targeted for hospital discharge within 48-56 hours.
NCT Number: NCT01860079
* When Primary percutaneous coronary intervention (PPCI) is performed expeditiously and at a high-volume centre, it is the optimal approach for ST elevation myocardial infarction (STEMI) . In contrast to the clarity of how to treat STEMI, there is no clear definition for when to discharge and which patient to discharge. * An early discharge strategy may be desired by all parties (financial health care provider, treating physician, nurse, patient, patient's relatives)involved in STEMI. * The main goal in our study is to test the hypothesis that an early discharge strategy within 48-56 hours in patients with successful PPCI is as safe as in those patients who stay longer (96-120 hours) as of a standard procedure.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Acibadem University, Istanbul, Turkey (Türkiye)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In the early discharge group, patients are actively targeted for hospital discharge within 48-56 hours.
Time frame: 30 DAYS
The primary end points were all cause mortality by 1 month and readmission due to reinfarction, unstable angina, arrhythmia, congestive heart failure, revascularization, stroke or major bleeding at 1 month.
Acibadem University
Other
Early Discharge After Primary Percutaneous Coronary Intervention: A Prospective Randomized Multi-center Trial (the EDAP PCI Trial)
Acronym: EDAPPCI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05605288
Arterial Occlusive Diseases, Arteriosclerosis
Charleroi, Belgium
View Trial DetailsNCT04573751
Cardiovascular Diseases, Heart Diseases
Tomsk, Tomsk Oblast, Russia
View Trial DetailsNCT05462730
Cardiomyopathies, Cardiovascular Diseases
Copenhagen, Capital Region, Denmark
View Trial DetailsNCT05848674
Cardiovascular Diseases, Heart Diseases
Belfast, Antrim, United Kingdom
View Trial Details